Cardiol Res

Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access

Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc

Journal website https://www.cardiologyres.org

Original Article

Volume 3, Number 6, December 2012, pages 271-276

Is There any Time Dependant Echocardiographical Finding in Chronic Hemodialysis Patients?

**Table 1.** Clinical Findings Between Three Groups
	Group 1 (≤ 6 mnt)	Group 2 (>6 mnt ≤ 3 yrs)	Group 3 (> 3 yrs)	P value
* P is two tailed significant.
Age (mean ± SD)	45.73 ± 13.25	52.50 ± 12.55	57.86 ± 9.44	0.005^*
Gender (male%)	12 (52.2%)	25 (45.5%)	14 (63.6%)	0.35
Diabetics (No.) (%)	4 (17.4%)	9 (16.4%)	6 (27.3%)	0.53
Hypertensive (No.) (%)	3 (13%)	12 (21.8%)	7 (31.8%)	0.31
Hyperlipidemia (No.) (%)	7 (30.4%)	12 (21.8%)	10 (15.5%)	0.11
Current smoking (No.) (%)	2 (8.7%)	3 (5.5%)	2 (9.1%)	-----
Positive family history of CAD (No.) (%)	4 (17.4%)	6 (10.9%)	2 (9.1%)	0.64
Hemodialysis time (per week)	3.04 ± 0.20	2.78 ± 0.41	2.63 ± 0.49	0.003^*
Systolic Blood pressure (mean ± SD)	131.51 ± 9.46	128.73 ± 9.72	133.64 ± 16.56	0.21
Diastolic Blood pressure (mean ± SD)	84.78 ± 9.22	80.72 ± 8.73	87.72 ± 12.22	0.01^*
Weight gain (mean ± SD)	1.24 ± 0.56	1.09 ± 0.23	1.46 ± 0.82	0.01^*

Table 1. Clinical Findings Between Three Groups

Group 1 (≤ 6 mnt)

Group 2 (>6 mnt ≤ 3 yrs)

Group 3 (> 3 yrs)

P value

* P is two tailed significant.

Age (mean ± SD)

45.73 ± 13.25

52.50 ± 12.55

57.86 ± 9.44

0.005^*

Gender (male%)

12 (52.2%)

25 (45.5%)

14 (63.6%)

0.35

Diabetics (No.) (%)

4 (17.4%)

9 (16.4%)

6 (27.3%)

0.53

Hypertensive (No.) (%)

3 (13%)

12 (21.8%)

7 (31.8%)

0.31

Hyperlipidemia (No.) (%)

7 (30.4%)

12 (21.8%)

10 (15.5%)

0.11

Current smoking (No.) (%)

2 (8.7%)

3 (5.5%)

2 (9.1%)

-----

Positive family history of CAD (No.) (%)

4 (17.4%)

6 (10.9%)

2 (9.1%)

0.64

Hemodialysis time (per week)

3.04 ± 0.20

2.78 ± 0.41

2.63 ± 0.49

0.003^*

Systolic Blood pressure (mean ± SD)

131.51 ± 9.46

128.73 ± 9.72

133.64 ± 16.56

0.21

Diastolic Blood pressure (mean ± SD)

84.78 ± 9.22

80.72 ± 8.73

87.72 ± 12.22

0.01^*

Weight gain (mean ± SD)

1.24 ± 0.56

1.09 ± 0.23

1.46 ± 0.82

0.01^*

**Table 2.** Laboratory Findings Between Three Groups
	Group 1 (≤ 6 mnt)	Group 2 (> 6 mnt ≤ 3 yrs)	Group 3 (> 3 yrs)	P value
* P is two tailed significant.
Fasting blood sugar (mean ± SD)	119 ± 20.02	109.07 ± 22.35	118 ± 29.21	0.14
Blood urea nitrogen (mean ± SD)	70.78 ± 16.72	56.21 ± 22.19	64.27 ± 19.63	0.01^*
Creatinine (mean ± SD)	5.18 ± 1.62	5.03 ± 1.96	6.27 ± 2.45	0.05
Albumin (mean ± SD)	3.59 ± 1.21	2.90 ± 0.70	2.89 ± 0.69	0.007^*
Sodium (mean ± SD)	145.13 ± 3.92	144.47 ± 3.91	144.52 ± 5.17	0.81
Potassium (mean ± SD)	4.90 ± 0.51	5.62 ± 0.82	5.40 ± 0.85	0.002^*
Calcium (mean ± SD)	7.90 ± 0.74	7.91 ± 0.92	7.47 ± 1.34	0.2
Phosphorus (mean ± SD)	4.35 ± 1.13	4.57 ± 1.41	4.96 ± 1.35	0.32
Cholesterol (mean ± SD)	144.26 ± 31.56	162.29 ± 42.46	168.05 ± 26.71	0.07
Hemoglobin (mean ± SD)	12.83 ± 0.88	12.28 ± 1.68	11.80 ± 1.96	0.1

Table 2. Laboratory Findings Between Three Groups

Group 1 (≤ 6 mnt)

Group 2 (> 6 mnt ≤ 3 yrs)

Group 3 (> 3 yrs)

P value

* P is two tailed significant.

Fasting blood sugar (mean ± SD)

119 ± 20.02

109.07 ± 22.35

118 ± 29.21

0.14

Blood urea nitrogen (mean ± SD)

70.78 ± 16.72

56.21 ± 22.19

64.27 ± 19.63

0.01^*

Creatinine (mean ± SD)

5.18 ± 1.62

5.03 ± 1.96

6.27 ± 2.45

0.05

Albumin (mean ± SD)

3.59 ± 1.21

2.90 ± 0.70

2.89 ± 0.69

0.007^*

Sodium (mean ± SD)

145.13 ± 3.92

144.47 ± 3.91

144.52 ± 5.17

0.81

Potassium (mean ± SD)

4.90 ± 0.51

5.62 ± 0.82

5.40 ± 0.85

0.002^*

Calcium (mean ± SD)

7.90 ± 0.74

7.91 ± 0.92

7.47 ± 1.34

0.2

Phosphorus (mean ± SD)

4.35 ± 1.13

4.57 ± 1.41

4.96 ± 1.35

0.32

Cholesterol (mean ± SD)

144.26 ± 31.56

162.29 ± 42.46

168.05 ± 26.71

0.07

Hemoglobin (mean ± SD)

12.83 ± 0.88

12.28 ± 1.68

11.80 ± 1.96

0.1

**Table 3.** Echocardiographic Findings Between Groups
	Group 1 (≤ 6 mnt)	Group 2 (> 6 mnt ≤ 3 yrs)	Group 3 (> 3 yrs)	All	P value
LVEF: Left ventricular ejection fraction; LVH: Left Ventricle Hypertrophy; LA: Left atrium.
LVEF ≤ 50% (No.) (%)	5 (21.7%)	14 (25.5%)	9 (40.9%)	28%	0.29
LVH (No.) (%)	4 (17.4%)	15 (27.3%)	7 (31.8%)	26%	0.51
LA dilation (No.) (%)	4 (17.4%)	15 (27.3%)	7 (31.8%)	26%	0.51
Diastolic dysfunction (grade III, IV) (No.) (%)	1 (4.3%)	15 (27.3%)	6 (27.3%)	22%	0.06
Mitral insufficiency (No.) (%)	13 (56.5%)	36 (65.5%)	18 (81.8%)	67%	0.18
Mitral calcification (No.) (%)	0%	3 (5.5%)	0%	3%	----
Aortic Insufficiency (No.) (%)	0%	2 (3.6%)	1 (4.5%)	3%	----
Aortic calcification (No.) (%)	0%	1 (1.8%)	0%	1%	----
Pericardial effusion (No.) (%)	4 (17.4%)	24 (43.6%)	7 (31.8%)	35%	0.08

Table 3. Echocardiographic Findings Between Groups

Group 1 (≤ 6 mnt)

Group 2 (> 6 mnt ≤ 3 yrs)

Group 3 (> 3 yrs)

All

P value

LVEF: Left ventricular ejection fraction; LVH: Left Ventricle Hypertrophy; LA: Left atrium.

LVEF ≤ 50% (No.) (%)

5 (21.7%)

14 (25.5%)

9 (40.9%)

28%

0.29

LVH (No.) (%)

4 (17.4%)

15 (27.3%)

7 (31.8%)

26%

0.51

LA dilation (No.) (%)

4 (17.4%)

15 (27.3%)

7 (31.8%)

26%

0.51

Diastolic dysfunction (grade III, IV) (No.) (%)

1 (4.3%)

15 (27.3%)

6 (27.3%)

22%

0.06

Mitral insufficiency (No.) (%)

13 (56.5%)

36 (65.5%)

18 (81.8%)

67%

0.18

Mitral calcification (No.) (%)

3 (5.5%)

----

Aortic Insufficiency (No.) (%)

2 (3.6%)

1 (4.5%)

----

Aortic calcification (No.) (%)

1 (1.8%)

----

Pericardial effusion (No.) (%)

4 (17.4%)

24 (43.6%)

7 (31.8%)

35%

0.08